A Trial to Learn if REGN7999 is Safe and Well Tolerated, and How it Works in the Body of Healthy Participants

Name: A Trial to Learn if REGN7999 is Safe and Well Tolerated, and How it Works in the Body of Healthy Participants
Published: 2022
License: Public Domain

Regeneron Pharmaceuticals · 2022

ClinicalTrials.gov · Datasets · License: Public Domain · 2022

Open Source ↗

healthy

healthy, non-menstruating, transmembrane protease, serine 6 (tmprss6) antagonist, first in human (fih), human monoclonal antibody (mab), interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Trial to Learn if REGN7999 is Safe and Well Tolerated, and How it Works in the Body of Healthy Participants

Related documents